Killer Immunoglobulin-like Receptor Genes in Uveitis

REFERENCES

• Rajalingam R, Parham P, Abi-Rached L. Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol. 2004;172:356–369.
   Google Scholar
• Ashouri E, Farjadian S, Reed EF, Ghaderi A, Rajalingam R. KIR gene content diversity in four Iranian populations. Immunogenetics. 2009;61:483–492.
   PubMed Web of Science ®Google Scholar
• Middleton D, Gonzalez-Galarza F, Meenagh A, Gourraud PA. Diversity of KIR genes, alleles and haplotypes. In: Zimmer J, ed. Natural Killer Cells: At the Forefront of Modern Immunology. Heidelberg: Springer; 2010:63–91.
   Google Scholar
• Yawata M, Yawata N. NK cell KIR heterogeneity and evolution. In: Lotze MT, Thomson AW, eds. Natural Killer Cells: Basic Science and Clinical Applications. London: Elsevier; 2010:79–94.
   Google Scholar
• Kulkarni S, Martin MP, Carrington M. The yin and yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343–352.
   PubMed Web of Science ®Google Scholar
• Levinson RD, Du Z, Luo L, et al. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol. 2008;69:349–353.
   Google Scholar
• Levinson RD, Du Z, Luo L, et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008;9:249–258.
   PubMed Web of Science ®Google Scholar
• Levinson RD, Martin TM, Luo L, et al. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy. Invest Ophthalmol Vis Sci. 2010;51:1505–1510.
   PubMed Web of Science ®Google Scholar
• Levinson RD, Okada AA, Ashouri E, Keino H, Rajalingam R. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals. Hum Immunol. 2010;71:192–194.
   Google Scholar
• Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol. [Epub ahead of print].
   Google Scholar
• Gismondi A, Bernardini G, Santoni A. NK cells and chemokines. In: Lotze MT, Thomson AW, eds. Natural Killer Cells: Basic Science and Clinical Applications. London: Elsevier; 2010:203–213.
   Google Scholar
• Wesa AK, Mailliard RB. Dendritic cells and NK cells. In: Lotze MT, Thomson AW, eds. Natural Killer Cells: Basic Science and Clinical Applications. London: Elsevier; 2010:239–253.
   Google Scholar
• Zingoni A, Cerboni C, Ardolino M, Santoni A. Modulation of T cell-mediated immune responses by natural killer cells. In: Zimmer J, ed. Natural Killer Cells: At the Forefront of Modern Immunology. Heidelberg: Springer; 2010:315–327.
   Google Scholar
• Terme M, Chaput N, Zitvogel L. Interactions between NK cells and regulatory T cells. In: Zimmer J, ed. Natural Killer Cells: At the Forefront of Modern Immunology. Heidelberg: Springer; 2010:329–343.
   Google Scholar
• Yuan D, Gao N, Jennings P. Interactions between B lymphocytes and NK cells: an update. In: Zimmer J, ed. Natural Killer Cells: At the Forefront of Modern Immunology. Heidelberg: Springer; 2010:345–368.
   Google Scholar
• Fadda L, Borhis G, Ahmed P, et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A. 2010;107:10160–10165.
   Google Scholar
• Chen Y, Shi Y, Cheng H, An YQ, Gao GF. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. IUBMB Life. 2009;61:579–590.
   Google Scholar
• van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. Int Immunol. 2009;21:145–153.
   PubMed Web of Science ®Google Scholar
• Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol. 2009;123:1004–1011.
   PubMed Web of Science ®Google Scholar
• Sieve AN, Meeks KD, Lee S, Berg RE. A novel immunoregulatory function for IL-23: inhibition of IL-12-dependent IFN-gamma production. Eur J Immunol. 2010;40(8):2236–2247.
   Google Scholar
• Takayama T, Kamada N, Chinen H, et al. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology. 2010;139(3):882–892.
   Google Scholar
• Passos ST, Silver JS, O’Hara AC, Sehy D, Stumhofer JS, Hunter CA. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol. 2010;184:1776–1783.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10:479–489.
   PubMed Web of Science ®Google Scholar
• Zimmer J, Hentges F, Andres E, Chalifour A. NK cell education and CIS interaction between inhibitory NK cell receptors and their ligands. In: Zimmer J, ed. Natural Killer Cells: At the Forefront of Modern Immunology. Heidelberg: Springer; 2010:93–108.
   Google Scholar
• Chan AT, Kollnberger SD, Wedderburn LR, Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum. 2005;52:3586–3595.
   PubMedGoogle Scholar
• Basu D, Liu Y, Wu A, et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol. 2009;183:3481–3487.
   PubMed Web of Science ®Google Scholar
• Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcet’s disease. Rheumatol Int. 2004;24:212–216.
   PubMed Web of Science ®Google Scholar
• Saruhan-Direskeneli G, Uyar FA, Cefle A, et al. Expression of KIR and C-type lectin receptors in Behcet’s disease. Rheumatology (Oxford). 2004;43:423–427.
   PubMed Web of Science ®Google Scholar
• Middleton D, Meenagh A, Sleator C, et al. No association of KIR genes with Behcet’s disease. Tissue Antigens. 2007;70:435–438.
   PubMed Web of Science ®Google Scholar
• Pagnoux C, Mahr A, Aouba A, et al. Extraocular manifestations of birdshot chorioretinopathy in 118 French patients. Presse Med. 2010;39:e97–e102.
   PubMedGoogle Scholar
• Donvito B, Monnet D, Tabary T, et al. A new HLA extended haplotype containing the A*2910 allele in birdshot retinochoroidopathy: susceptibility narrowed to the HLA molecule itself. Invest Ophthalmol Vis Sci. 2010;51:2525–2528.
   PubMed Web of Science ®Google Scholar
• Stewart-Jones GB, di Gleria K, Kollnberger S, McMichael AJ, Jones EY, Bowness P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol. 2005;35:341–351.
   Google Scholar
• Levinson RD, Rajalingam R, Park MS, et al. Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol. 2004;138:631–634.
   PubMed Web of Science ®Google Scholar
• Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics. 2007;59:1–15.
   PubMed Web of Science ®Google Scholar
• Levinson RD, See RF, Rajalingam R, et al. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada’s disease in Southern California. Hum Immunol. 2004;65:1477–1482.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Sakai J, Okada AA, Takada E, Usui M, Mizuguchi J. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol. 2002;240:314–321.
   Google Scholar
• Kitaichi N, Kotake S, Morohashi T, Onoe K, Ohno S, Taylor AW. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol. 2002;72:1117–1121.
   PubMed Web of Science ®Google Scholar
• Shao H, Van Kaer L, Sun SL, Kaplan HJ, Sun D. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J Autoimmun. 2003;21:37–45.
   PubMed Web of Science ®Google Scholar
• Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol. 2005;174:5187–5191.
   PubMed Web of Science ®Google Scholar